The management of the obese patient in intensive care is fraught with difficulty, or so conventional wisdom would have us believe. Two recent studies add to the growing evidence that the obese patient is not significantly disadvantaged in terms of outcome following intensive care admission. Another study highlights the increasing burden of end-stage renal disease on intensive care unit resources with some interesting results. And there is more on citrate, the new anticoagulant!
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646314 | PMC |
http://dx.doi.org/10.1186/cc7138 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!